Prevalence of neural tube defect and its relative factors in south-west of Iran

Pakistan Journal of Medical Sciences

Volumn 23, Issue 4, 2007, Pages 654-656

  Behrooz, Ahmad ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Folic acid; Neural tube defect

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; HUMAN; INCIDENCE; IRAN; MATERNAL WELFARE; MENINGOCELE; MORBIDITY; NEURAL TUBE DEFECT; PREGNANCY; PREVALENCE; PRIMIGRAVIDA; SEX DIFFERENCE; SPINA BIFIDA; STATISTICAL SIGNIFICANCE;

EID: 34548444265     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nakano KK. Anencephaly A review. Dev Med Child Neural 1973;15:383-400.
2. Mulinare J, Erickson D. Prevention of neural tube defects. Teratology 1997;56:17-8.
3. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
4. Harris JA, Shaw GM. Neural tube defects - Why are rates high among population of Mexican descent? Environ Health Perspect 1995;103(supp 6):163-4.
5. Maclone TG. Central nervous system in: Sadler TW; Langman's medical embryology; Lippincot Company 1996;385-90.
6. Thomas MA. Some malformations and Diseases determined by multifactorial inheritance. Medical Genetics Principles and practice; Lea and Febrigue Company 1989: 240-243.
7. Lorber J. Malformation of neural tube closure. In: Larsen-WJ. Human Embryology; Churchill livingstone company 1997;22-95.
8. Haslem MA. Congenital anomalies of the central nervous system; in: Behrman RE. Text book of pediatrics. Nelson; Wbsunders Company; 2000;1803-6.
9. Duncan S, Merco S, Lopez I. Repeated Neural tube defects and valporate monotherapy suggest a pharmacogenetic abnormality. Epilepsia 2001;42(6):750-3.
10. Cunninghum FG, Gunt NF, leveno KJ, Gill strup LC, hauth JC, Wenstrom KD. In: Williams obstetrics; D-McGraw-Hill company 2001;956-60.
11. Hendricks KA. Neural tube defects along the Texas Mexico border; 1993-1995; AM J epidemiology 1999;149(12):1119-27.
12. Leach M. Prevention using folic Acid, a good method for reduction of neural tube defects in poland. Przegl-Lek 1999;55(6):334-6.
13. Rosch C. Incidence of neural tube defects in the Magdeburg administrative district. Gesund heit swesen 1998;60(10):563-6.
14. Rajab A. Neural tube defects and congenital hydrocephallus in the sultanate of Oman. J Tropical Ped 1998;44(5):300-3.
15. Haslam RH. Prenatal Diagnosis in: Singer SAM; Human genetics; WH Freeman company 1985;122-4.
16. Gilman S. Genetics disorders with multifactorial inheritance in: Tampson MH, Mclinners R, Willard H; Genetics in medicine; WB saunders company; 1991;349-57.
17. Elwood JM, Little J, Elwood JH. Epidemiology and control of neural tube defects. New York: Oxford university press.1992.
18. Geisel J. Folic acid and neural tube defects in pregnancy; JPNN 2003;17(4):268-79.
19. Birnbacher R, Messerschmidt AM, Pollak AP. Diagnosis and prevention of neural tube defects. Current opinion in Urology 2002;12:461-4.